Literature DB >> 25628794

MiR-223 suppresses endometrial carcinoma cells proliferation by targeting IGF-1R.

Kai Huang1, Xiyuan Dong1, Cong Sui1, Dan Hu1, Ting Xiong1, Shujie Liao1, Hanwang Zhang1.   

Abstract

MicroRNAs were recently found to participate in oncogenesis and growth of various tumors. We hypothesized that microRNA-223 (miR-223) plays a role in endometrial carcinoma growth. In this study, we transfected RL95-2 cells with lentivirus containing miR-223 precursor to establish a miR-223 over-expression model. Proliferation of the cells was greatly inhibited when miR-223 was over-expressed, and cell cycle progress was blocked in G0/G1 phase. To investigate the mechanisms involved, we scanned the putative target genes of miR-223 using bioinformatics, and confirmed that insulin-like growth factor-1 receptor (IGF-1R) was a functional target of miR-223 using quantitative PCR, Western blot and luciferase reporter assay. Meanwhile, over-expressed miR-223 was found to regulate the expression of IGF-1R by repressing protein translation. Silencing IGF-1R with small interfering RNA resulted in similar effect as miR-223 overexpression. Therefore, our data suggest that miR-223 regulates RL95-2 cells proliferation and cell cycle progress by targeting IGF-1R.

Entities:  

Keywords:  MiR-223; cell proliferation; endometrial carcinoma cell; in vitro; insulin-like growth factor-1 receptor

Year:  2014        PMID: 25628794      PMCID: PMC4297351     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  34 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis.

Authors:  Francesco Fazi; Alessandro Rosa; Alessandro Fatica; Vania Gelmetti; Maria Laura De Marchis; Clara Nervi; Irene Bozzoni
Journal:  Cell       Date:  2005-12-02       Impact factor: 41.582

3.  p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapy.

Authors:  Zohar Attias-Geva; Itay Bentov; Dvora Kidron; Keren Amichay; Rive Sarfstein; Ami Fishman; Ilan Bruchim; Haim Werner
Journal:  Eur J Cancer       Date:  2011-10-25       Impact factor: 9.162

Review 4.  Targeting IGF-1 signaling pathways in gynecologic malignancies.

Authors:  Ilan Bruchim; Haim Werner
Journal:  Expert Opin Ther Targets       Date:  2013-01-07       Impact factor: 6.902

5.  Inhibitory effect of siRNA targeting IGF-1R on endometrial carcinoma.

Authors:  Shanrong Shu; Xiaomao Li; Yuebo Yang; Yu Zhang; Tian Li; Changyan Liang; Jing Wan
Journal:  Int Immunopharmacol       Date:  2010-12-09       Impact factor: 4.932

6.  Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium.

Authors:  Adrienne S McCampbell; Russell R Broaddus; David S Loose; Peter J A Davies
Journal:  Clin Cancer Res       Date:  2006-11-01       Impact factor: 12.531

7.  Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells.

Authors:  S Masciarelli; G Fontemaggi; S Di Agostino; S Donzelli; E Carcarino; S Strano; G Blandino
Journal:  Oncogene       Date:  2013-04-15       Impact factor: 9.867

8.  MicroRNAs modulate hematopoietic lineage differentiation.

Authors:  Chang-Zheng Chen; Ling Li; Harvey F Lodish; David P Bartel
Journal:  Science       Date:  2003-12-04       Impact factor: 47.728

9.  Downregulation of miR-223 and miR-153 mediates mechanical stretch-stimulated proliferation of venous smooth muscle cells via activation of the insulin-like growth factor-1 receptor.

Authors:  Lei Song; Ping Duan; Ping Guo; Dianwei Li; Songtao Li; Yuan Xu; Qiang Zhou
Journal:  Arch Biochem Biophys       Date:  2012-10-06       Impact factor: 4.013

10.  A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation.

Authors:  Guoqing Zhuang; Cong Meng; Xin Guo; Patali S Cheruku; Lei Shi; Hang Xu; Honggui Li; Gang Wang; Ashley R Evans; Stephen Safe; Chaodong Wu; Beiyan Zhou
Journal:  Circulation       Date:  2012-05-11       Impact factor: 29.690

View more
  15 in total

1.  MicroRNA-802 plays a tumour suppressive role in tongue squamous cell carcinoma through directly targeting MAP2K4.

Authors:  Xiaozhen Wu; Zuode Gong; Lanying Sun; Long Ma; Qibao Wang
Journal:  Cell Prolif       Date:  2017-03-20       Impact factor: 6.831

2.  MicroRNA-223-3p suppresses leukemia inhibitory factor expression and pinopodes formation during embryo implantation in mice.

Authors:  Xiyuan Dong; Cong Sui; Kai Huang; Lan Wang; Dan Hu; Ting Xiong; Rui Wang; Hanwang Zhang
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

3.  Circulating microRNA signature of steroid-induced osteonecrosis of the femoral head.

Authors:  Zheng Li; Chao Jiang; Xingye Li; William K K Wu; Xi Chen; Shibai Zhu; Chanhua Ye; Matthew T V Chan; Wenwei Qian
Journal:  Cell Prolif       Date:  2017-12-04       Impact factor: 6.831

4.  MiR-217 promotes cutaneous squamous cell carcinoma progression by targeting PTRF.

Authors:  Ming Bai; Mingzi Zhang; Fei Long; Nanze Yu; Ang Zeng; Xiaojun Wang
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

5.  Long-term soy consumption and tumor tissue MicroRNA and gene expression in triple-negative breast cancer.

Authors:  Xingyi Guo; Qiuyin Cai; Pingping Bao; Jie Wu; Wanqing Wen; Fei Ye; Wei Zheng; Ying Zheng; Xiao-Ou Shu
Journal:  Cancer       Date:  2016-05-16       Impact factor: 6.860

6.  MicroRNA-223 inhibits deposition of the extracellular matrix by airway smooth muscle cells through targeting IGF-1R in the PI3K/Akt pathway.

Authors:  Dongdong Liu; Jing Pan; Deyu Zhao; Feng Liu
Journal:  Am J Transl Res       Date:  2018-03-15       Impact factor: 4.060

7.  miR-223 contributes to the AGE-promoted apoptosis via down-regulating insulin-like growth factor 1 receptor in osteoblasts.

Authors:  Yi Qin; Jichao Ye; Peng Wang; Liangbin Gao; Suwei Wang; Huiyong Shen
Journal:  Biosci Rep       Date:  2016-04-05       Impact factor: 3.840

8.  MicroRNA-610 suppresses osteosarcoma oncogenicity via targeting TWIST1 expression.

Authors:  Chi Jin; Yongjian Feng; Yongjian Ni; Zhonglin Shan
Journal:  Oncotarget       Date:  2017-04-11

9.  MicroRNA-448 suppresses osteosarcoma cell proliferation and invasion through targeting EPHA7.

Authors:  Xiangkun Wu; Lihua Yan; Yongxi Liu; Wenfeng Xian; Liuyu Wang; Xunmeng Ding
Journal:  PLoS One       Date:  2017-06-12       Impact factor: 3.240

10.  MicroRNA-223 promotes mast cell apoptosis by targeting the insulin-like growth factor 1 receptor.

Authors:  Haiyan Gao; Huan Deng; Hong Xu; Qianyuan Yang; Yao Zhou; Jiamin Zhang; Deyu Zhao; Feng Liu
Journal:  Exp Ther Med       Date:  2016-04-05       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.